透過您的圖書館登入
IP:18.225.149.32
  • 學位論文

D-甲硫胺酸改善順鉑誘導大鼠心臟毒性以及厭食之探討

Improvement of Cisplatin-induced Cardiotoxicity and Anorexia by D-methionine in Rats

指導教授 : 歐珠琴

摘要


順鉑 (Cisplatin) 是一種含鉑且常見的化學治療藥物,由於cisplatin會產生嚴重的副作用,如:耳毒性、腎毒性、神經毒性、心臟毒性、厭食/惡病質及腸胃道毒性等。D型甲硫胺酸 (D-methionine) 是L型甲硫胺酸的右旋異構物,目前已知藉由其抗氧化特性,降低cisplatin所引起的耳毒性與腎毒性,然而,D-methionine對於cisplatin引起的厭食與心臟毒性是否具有保護作用,尚未被探討,本實驗藉由大鼠模式探討D-methionine是否可改善cispaltin所誘導的厭食與心臟毒性。我們將Wistar品系雄性大鼠隨機分成四組,每組5-8隻,其中,控制組 (Control) 與順鉑組 (Cisplatin) 在實驗的前3天至第18天,管餵一般飲用水,且分別在實驗的第1、8、15天進行腹腔注射0.9%NaCl與cisplatin,劑量皆為5 mg/kg;順鉑合併D型甲硫胺酸組 (Cisplatin+D-methionine) 與D型甲硫胺酸組 (D-methionine) 分別在注射第一劑cisplatin與0.9%NaCl的前三天,開始灌食D-methionine 300 mg/kg直到實驗的第18天,並分別在實驗的第1、8、15天進行腹腔注射cisplatin與0.9%NaCl,劑量皆為5 mg/kg,最後在實驗的第19天進行犧牲。我們檢測與食慾調節相關的因子 (例如:飢餓素、瘦體素、色胺酸羥化酶1、5-HT3 receptor、5-HT2C receptor、NPY、AgRP、POMC、CART) ,藉由生理紀錄器測量心跳、收縮壓、舒張壓、平均動脈壓、心電圖,以及心臟毒性指標 (CK-MB、LDH) 與發炎反應 (IL-6、IL-1β、TNF-α) 、氧化壓力 (MDA、GSH、GPx、SOD) ,作為心臟毒性指標檢測。研究結果顯示,在厭食方面,D-methionine可以顯著改善cisplatin誘導的體重與攝食量降低,減少胃內容物殘留量並增加胃排空,透過降低腸道中色胺酸羥化酶1 (TPH1) 的活性、5- HT3 receptor的陽性反應以及降低下視丘中5-HT2C receptor基因表現等改善胃腸功能失調進而減緩厭食的發生;此外,D-methionine透過增加血清中瘦體素的含量,而促進下視丘中POMC與CART的基因表現,與降低NPY與AgRP的基因表現,以維持能量的平衡狀態。在心臟毒性方面,D-methionine可以輕微改善心臟功能異常,包括心跳、收縮壓、舒張壓以及平均動脈壓,但是無法改善cisplatin所引起的心臟毒性 (LDH與CK-MB) 與發炎反應 (IL-6、IL-1β、TNF-α) ;我們也發現cisplatin並不會造成心律不整、胸主動脈受損、心臟組織損傷以及氧化壓力。 因此,口服D-methionine具有改善cisplatin所引起厭食的潛力,但無法減緩心臟毒性。

關鍵字

D型甲硫胺酸 順鉑 厭食 心臟毒性

並列摘要


Cisplatin, a platinum-containing compound is one of the most common chemotherapeutic drugs and leads to many serious side effects, such as ototoxicity, nephrotoxicity, neurotoxicity, cardiotoxicity, anorexia/cachexia and gastrointestinal toxicity. D-methionine, a dextral isomer of L-methionine is a sulfur-containing antioxidant. Owing to its antioxidant properties, D-methionine may attenuate ototoxicity and nephrotoxicity caused by cisplatin. However, effects of D-methionine on cisplatin-induced anorexia and cardiotoxicity have not been explored yet. In this study, we investigated whether D-methionine could attenuate cisplatin-induced anorexia and cardiotoxicity in rat model. Male Wistar rats were randomly divided into four groups of which from five to eight rats each. The control group and cisplatin group were administrated water from three days before to the 18th day of the experiment and injected with 0.9% NaCl and cisplatin (5 mg/kg) via intraperitoneal (i.p.) on the 1st, 8th and 15th day of the experiment respectively. Cisplatin plus D-methionine group and D-methionine alone group were pre-administrated daily with D-methionine (300 mg/kg) 3 day before cisplatin and 0.9% NaCl treatment until the study is completed. Also cisplatin and 0.9% NaCl were i.p. injected on the 1st, 8th and 15th day of the experiment, respectively. All animals were sacrificed on day 19 of the experiment. We detected the appetite regulated factors such as ghrelin, leptin, tryptophan hydroxylase 1, 5-HT3 receptor, 5-HT2C receptor, NPY, AgRP, POMC, CART, and used physiological recording machine to determine heart rate, systolic blood pressure, diastolic blood pressure, mean arterial pressure and electrocardiogram. The cardiotoxicity marker (CK-MB, LDH) ,inflammatory response (IL-6, IL-1β, TNF-α) and oxidative stress (MDA, GSH, GPx, SOD) were measured and deemed as cardiotoxicity index. As for anorexia, the results showed that D-methionine can significantly improve cisplatin-induced weight loss and food intake, decrease gastric contents, enhance gastric emptying in the stomach tissue. D-methionine could reduce the activity of tryptophan hydroxylase 1 (TPH1), increase the positive response of 5-HT3 receptor in the intestine and decrease gene expression of 5-HT2C receptor in the hypothalamus in cisplatin-treated rats. In addition, to maintain energy balance in cisplatin-treated rats, D-methionine increased plasma levels of leptin in serum, which lead to enhance the gene expression of POMC, CART and decrease the gene expression of NPY and AgRP. By the results of cisplatin-induced cardiotoxicity, we found D-methionine can slightly improve the abnormal status of heart rate, systolic blood pressure, diastolic blood pressure, and mean arterial pressure, while it cannot ameliorate LDH and CK-MB activity and inflammatory response (IL-6 , IL-1β, TNF-α) after cisplatin injection. Besides, cisplatin did not cause arrhythmia, thoracic aorta damage, cardiac tissue damage and oxidative stress. These results indicate that oral D-methionine may have potential for improving cisplatin-induced anorexia but can not ameliorate cisplatin induced cardiotoxicity.

並列關鍵字

D- methionine cisplatin anorexia cardiotoxicity

參考文獻


Cloven NG, Re A, McHale MT, Burger RA, DiSaia PJ, Rose GS, Campbell KC, Fan H (2000) Evaluation of D-methionine as a cytoprotectant in cisplatin treatment of an animal model for ovarian cancer. Anticancer Res 20: 4205-9
Abdellatief SA, Galal AA, Farouk SM, Abdel-Daim MM (2017) Ameliorative effect of parsley oil on cisplatin-induced hepato-cardiotoxicity: A biochemical, histopathological, and immunohistochemical study. Biomed Pharmacother 86: 482-491
Abe M, Hirashima Y, Kasamatsu Y, Kado N, Komeda S, Kuji S, Tanaka A, Takahashi N, Takekuma M, Hihara H, Ichikawa Y, Itonaga Y, Hirakawa T, Nasu K, Miyagi K, Murakami J, Ito K (2016) Efficacy and safety of olanzapine combined with aprepitant, palonosetron, and dexamethasone for preventing nausea and vomiting induced by cisplatin-based chemotherapy in gynecological cancer: KCOG-G1301 phase II trial. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 24: 675-682
Adali F, Gonul Y, Kocak A, Yuksel Y, Ozkececi G, Ozdemir C, Tunay K, Bozkurt MF, Sen OG (2016) Effects of thymoquinone against cisplatin-induced cardiac injury in rats. Acta Cir Bras 31: 271-7
Adam CL, Archer ZA, Findlay PA, Thomas L, Marie M (2002) Hypothalamic gene expression in sheep for cocaine- and amphetamine-regulated transcript, pro-opiomelanocortin, neuropeptide Y, agouti-related peptide and leptin receptor and responses to negative energy balance. Neuroendocrinology 75: 250-6

延伸閱讀